DARE - Daré Bioscience Inc. (DARE) Q4 2023 Earnings Call Transcript
2024-03-28 20:47:08 ET
Daré Bioscience, Inc. (DARE)
Q4 2023 Earnings Conference Call
March 28, 2024, 4:30 PM ET
Company Participants
Sabrina Martucci Johnson - President and CEO
MarDee Haring-Layton - Chief Accounting Officer
Conference Call Participants
Douglas Tsao - H.C. Wainright
Will Hidell - Brookline Capital Markets
Presentation
Operator
Welcome to the conference call hosted by Daré Bioscience to review the company’s Fourth Quarter Financial Results and to provide a General Business Update. This call is being recorded. My name is Lisa, and I will be your operator today. With us today from Daré are Sabrina Martucci Johnson, President and Chief Executive Officer; and MarDee Haring-Layton, Chief Accounting Officer.
Ms. Johnson, please proceed.
Sabrina Martucci Johnson
Thank you. Good afternoon. And welcome to the Daré Bioscience financial results and business update call for the year ended December 31, 2023. Today, we’ll review our financial results for 2023 and discuss developments and expectations for our pipeline and portfolio.
Before we begin, I’d like to remind you that today’s discussion will include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.
Any statements made during this call that are not statements of historical facts should be considered forward-looking statements. Actual results or events could differ materially from those anticipated or implied by these statements due to known and unknown risks and uncertainties....
Daré Bioscience, Inc. (DARE) Q4 2023 Earnings Call Transcript